Frankfurt - Delayed Quote EUR

IRADIMED CORPORATION (46K.F)

51.00

+5.60

+(12.33%)

At close: May 30 at 8:01:50 AM GMT+2

IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System

WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation MRidium® 3870 IV Infusion Pump System. This advanced, MRI-compatible infusion pump extends Iradimed’s unique position as the world’s only supplier of non-magnetic MRI infusion pump devices, established with our first-gener

GlobeNewswire 3 days ago

IRMD
Exploring 3 Undiscovered Gems In The US Market

Over the last 7 days, the United States market has risen 2.9%, contributing to a 12% increase over the past year, with earnings expected to grow by 14% annually. In this dynamic environment, identifying stocks that are poised for growth yet remain underappreciated can offer unique opportunities for investors seeking to capitalize on emerging potential in the market.

Simply Wall St. 13 days ago

TSSI

GNTY

IRMD
IRADIMED CORPORATION (NASDAQ:IRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$71.00

As you might know, IRADIMED CORPORATION ( NASDAQ:IRMD ) recently reported its quarterly numbers. IRADIMED reported in...

Simply Wall St. 23 days ago

IRMD
IRADIMED First Quarter 2025 Earnings: EPS Misses Expectations

IRADIMED ( NASDAQ:IRMD ) First Quarter 2025 Results Key Financial Results Revenue: US$19.5m (up 11% from 1Q 2024). Net...

Simply Wall St. 26 days ago

IRMD
iRadimed Corp (IRMD) Q1 2025 Earnings Call Highlights: Record Revenue Growth Amidst Global ...

iRadimed Corp (IRMD) reports its 15th consecutive quarter of record revenues, with significant domestic growth offsetting international sales decline.

GuruFocus.com 26 days ago

IRMD
IRadimed (IRMD) Lags Q1 Earnings Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of -2.33% and 0.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 27 days ago

IRMD
IRadimed: Q1 Earnings Snapshot

IRMD) on Monday reported earnings of $4.7 million in its first quarter. The Winter Springs, Florida-based company said it had net income of 37 cents per share. Earnings, adjusted for stock option expense, were 42 cents per share.

Associated Press Finance 27 days ago

IRMD
IRADIMED CORPORATION Announces First Quarter 2025 Financial Results

Announces Regular Quarterly Cash Dividend of $0.17 Per Share Reaffirms Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $19.5 million for the first quarter of 2025, an increase of $1.9 million or 11%, compared to the same period in 2024.Reports GAAP diluted EPS of $0.37 and non-GAAP diluted EPS of $0.42 for the first quarter of 2025, which are increases of 16% and 17%, respectively, compared to the same period in 2024.Declares a regular quarterly cash dividend of $0.17 per

GlobeNewswire 27 days ago

IRMD
CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025

WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by IRADIMED CORPORATION (NASDAQ: IRMD), please note that in the first paragraph the date of the earnings call should read "Monday, May 5, 2025" instead of "Friday, May 5, 2025". The corrected release follows: IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 first quarter financial results before the market opens on Monday, May 5, 2025. Iradi

GlobeNewswire last month

IRMD
IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025

WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 first quarter financial results before the market opens on Friday, May 5, 2025. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-ser

GlobeNewswire last month

IRMD
Under The Bonnet, IRADIMED's (NASDAQ:IRMD) Returns Look Impressive

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...

Simply Wall St. last month

IRMD
Integer (ITGR) Beats Q1 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of 3.15% and 1.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

IRMD
Undiscovered Gems in the US Market for April 2025

As the U.S. market navigates a landscape marked by tariff tensions and economic uncertainties, major indices like the Dow Jones Industrial Average are experiencing volatility, yet remain poised for potential weekly gains. In this climate of fluctuating investor sentiment and economic indicators, identifying promising small-cap stocks requires a keen eye for companies with strong fundamentals and resilience to macroeconomic pressures.

Simply Wall St. last month

TILE

IRMD

UVSP
Here's Why We Think IRADIMED (NASDAQ:IRMD) Is Well Worth Watching

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Simply Wall St. 2 months ago

IRMD
Undiscovered Gems in the US Market for March 2025

Over the last 7 days, the United States market has experienced a 4.4% drop, yet it remains up by 7.5% over the past year with earnings forecasted to grow by 14% annually. In this dynamic environment, identifying stocks that are not only resilient but also positioned for growth can be crucial for investors seeking to uncover hidden opportunities in the market.

Simply Wall St. 2 months ago

IRMD

UNTY

EZPW
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference

WINTER SPRINGS, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that it will participate in the 37th Annual Roth Conference. Iradimed’s CFO, Jack Glenn, and CCO, Jeff Chiprin, will host one-on-one meetings between company management and investors at the 37th Annual Roth Conference, which will be held at the Laguna Cliffs Marriott in Dana Point, CA, on March 17 and 18, 2025. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in

GlobeNewswire 2 months ago

IRMD
Is Weakness In IRADIMED CORPORATION (NASDAQ:IRMD) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

It is hard to get excited after looking at IRADIMED's (NASDAQ:IRMD) recent performance, when its stock has declined...

Simply Wall St. 2 months ago

IRMD
Earnings Update: Here's Why Analysts Just Lifted Their IRADIMED CORPORATION (NASDAQ:IRMD) Price Target To US$71.00

IRADIMED CORPORATION ( NASDAQ:IRMD ) shareholders are probably feeling a little disappointed, since its shares fell...

Simply Wall St. 3 months ago

IRMD
iRadimed Corp (IRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Shifts

iRadimed Corp (IRMD) reports its 14th consecutive record quarter with strong domestic sales and strategic focus on monitor business for 2025.

GuruFocus.com 3 months ago

IRMD
IRadimed (IRMD) Lags Q4 Earnings Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of -2.22% and 1.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 3 months ago

IRMD

Performance Overview

Return	46K.F	S&P 500 (^GSPC)
YTD	+0.68%	+0.51%
1-Year	+32.52%	+12.92%
3-Year	+75.78%	+42.17%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IRADIMED CORPORATION (46K.F)

IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System

Exploring 3 Undiscovered Gems In The US Market

IRADIMED CORPORATION (NASDAQ:IRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$71.00

IRADIMED First Quarter 2025 Earnings: EPS Misses Expectations

iRadimed Corp (IRMD) Q1 2025 Earnings Call Highlights: Record Revenue Growth Amidst Global ...

IRadimed (IRMD) Lags Q1 Earnings Estimates

IRadimed: Q1 Earnings Snapshot

IRADIMED CORPORATION Announces First Quarter 2025 Financial Results

CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025

IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025

Under The Bonnet, IRADIMED's (NASDAQ:IRMD) Returns Look Impressive

Integer (ITGR) Beats Q1 Earnings and Revenue Estimates

Undiscovered Gems in the US Market for April 2025

Here's Why We Think IRADIMED (NASDAQ:IRMD) Is Well Worth Watching

Undiscovered Gems in the US Market for March 2025

IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference

Is Weakness In IRADIMED CORPORATION (NASDAQ:IRMD) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Earnings Update: Here's Why Analysts Just Lifted Their IRADIMED CORPORATION (NASDAQ:IRMD) Price Target To US$71.00

iRadimed Corp (IRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Shifts

IRadimed (IRMD) Lags Q4 Earnings Estimates

Performance Overview